Start Here

Mike's Top Healthcare Stocks Blow Away the Outstanding Performance of the S&P 500

Year to date (YTD) the S&P 500 is up by about 18% even with the recent sell off.

As our clients and subscribers to our newsletters will attest, we have advised remaining in the market at full speed ahead thus far in 2013.

And we have kept our clients and subscribers in the stock market at all times since March 9, 2009, the date of the exact bottom in the US stock market, other than the small handful of periods when the market sold off hard.

In every case we predicted these sell offs and advised our clients accordingly.

This is not an advertisement meant to remind our audience that Mike Stathis the world’s leading market forecaster and one of the top investment minds. We wanted to remind those of you who have been conned by gold charlatans and fear-mongering perma-bears that you have really been taken to the cleaners.

I am not going to even remind you that gold and silver are down by about 22% and 29%, respectively versus the 18% and 26% upside in the S&P 500 and Nasdaq thus far in 2013. Okay, I'm sure you want to see a chart anyway.

 

 

By any standards the performance of the US stock market for 2013 has been blistering.

Although many securities we have recommended have significantly outperformed the S&P 500, we wanted to focus on the healthcare industry here, due to all of the discussions surrounding Obamacare.

Here, we review the YTD performance of the only two healthcare stocks we cover in the Intelligent Investor as well as the top rated healthcare stock in the Dividend Gems Recommended Securities list. The chart below shows this.

 

 

As you can see, the top-rated healthcare security covered in Dividend Gems has returned 43% this year not counting dividends. 

Meanwhile, the two healthcare stocks covered in the Intelligent Investor have returned 34% in 2013. This compares with a very impressive 18% performance in the S&P 500. 

Folks, you can lead the horse to the water but you can’t make it drink.

If you aren’t outperforming the market, you are losing the game. And if you are paying financial advisers to underperform the market, you are foolish.

Whether you are wise enough to fire your underperforming financial advisor or fund manager or not, if you do not have access to our research you are asking for huge losses and you are missing huge gains.

 

Check Our Current Newsletter Promotions

 

 

 


Restrictions Against Reproduction: No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning, or otherwise, except as permitted under Section 107 or 108 of the 1976 United States Copyright Act, without the prior written permission of the copyright owner and the Publisher.

These articles and commentaries cannot be reposted or used in any publications for which there is any revenue generated directly or indirectly. These articles cannot be used to enhance the viewer appeal of any website, including any ad revenue on the website, other than those sites for which specific written permission has been granted. Any such violations are unlawful and violators will be prosecuted in accordance with these laws.

Article 19 of the United Nations' Universal Declaration of Human Rights: Everyone has the right to freedom of opinion and expression; this right includes freedom to hold opinions without interference and to seek, receive and impart information and ideas through any media and regardless of frontiers.

This publication (written, audio and video) represents the commentary and/or criticisms from Mike Stathis or other individuals affiliated with Mike Stathis or AVA Investment Analytics (referred to hereafter as the “author”). Therefore, the commentary and/or criticisms only serve as an opinion and therefore should not be taken to be factual representations, regardless of what might be stated in these commentaries/criticisms. There is always a possibility that the author has made one or more unintentional errors, misspoke, misinterpreted information, and/or excluded information which might have altered the commentary and/or criticisms. Hence, you are advised to conduct your own independent investigations so that you can form your own conclusions. We encourage the public to contact us if we have made any errors in statements or assumptions. We also encourage the public to contact us if we have left out relevant information which might alter our conclusions. We cannot promise a response, but we will consider all valid information.


AVA Investment Analytics Clients Cash in on MAKO

Recently, Stryker (SYK) announced its intent to purchase MAKO Surgical (MAKO) for $1.65 billion, sending shares to nearly $30 after holding the mid- to low-teens for nearly a year.

America's Healthcare Solution

Regardless what you may hear and read from Americas tightly-controlled media monopoly, the healthcare industry will continue its string of excessive profits at the expense of consumers and taxpayers....

The Truth About Healthcare

This video is the first of (hopefully) many more to come in the future on the realities behind Americas healthcare system. 

America's Healthcare Solution Proven to be a Crystal Ball

I don’t particularly enjoy boasting about myself, but as you can imagine, being on the media’s black list requires me to serve as my own cheerleader. It’s shocking how the media cont...

0:00
0:00